Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Entera Bio (ENTX) Gross Profit (2019 - 2024)

Entera Bio has reported Gross Profit over the past 5 years, most recently at $9000.0 for Q2 2024.

  • For the quarter ending Q2 2024, Gross Profit changed N/A year-over-year to $9000.0, compared with a TTM value of $9000.0 through Mar 2025, changed N/A, and an annual FY2024 reading of $9000.0, changed N/A over the prior year.
  • Gross Profit came in at $9000.0 for Q2 2024, up from $6000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $84000.0 in Q1 2021 to a low of $2000.0 in Q3 2022.
  • Median Gross Profit over the past 4 years was $16500.0 (2020), compared with a mean of $25416.7.
  • The sharpest move saw Gross Profit surged 516.67% in 2020, then tumbled 97.33% in 2022.
  • Over 4 years, Gross Profit stood at $25000.0 in 2020, then grew by 16.0% to $29000.0 in 2021, then plummeted by 79.31% to $6000.0 in 2022, then skyrocketed by 50.0% to $9000.0 in 2024.
  • Per Business Quant, the three most recent readings for ENTX's Gross Profit are $9000.0 (Q2 2024), $6000.0 (Q4 2022), and $2000.0 (Q3 2022).